home / stock / cmnd / cmnd news

CMND News and Press, Caleminder Inc From 05/07/24

Stock Information
Company Name: Caleminder Inc
Stock Symbol: CMND
Market: OTC
Website: clearmindmedicine.com
Menu
CMND CMND Quote CMND Short CMND News CMND Articles CMND Message Board
Get CMND Alerts

News, Short Squeeze, Breakout and More Instantly...
CMND - Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment

Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated ...
CMND - Clearmind Applies to Cease Being a Reporting Issuer in Canada

Vancouver, Canada, April 30, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) (" Clearmind " or the “ Company ”), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

CMND - Clearmind signs agreement for psychedelic compounds for mental disorders treatment

2024-04-17 08:59:42 ET More on Clearmind Medicine Inc. Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation SciSparc gains as Clearmind partnership yields 3 new international patent applications Financial information for Clearmind Medici...

CMND - Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated ...
CMND - Notable Newsmakers

2024-04-10 09:19:47 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- ABVC BioPharma, Inc. (NASDAQ: ABVC ), Clearmind Medicine Inc. (NASDAQ: CMND ), Brera Holding (NASDAQ: BREA ), Goldman Sachs (NYSE: GS ), and JP Morgan (NYSE: JPM ). ABVC B...

CMND - Clearmind Medicine Applies for Psychedelic-Based Eating Disorder Treatment Patent

2024-04-10 08:24:27 ET DENVER, Colo., Apr 10, 2024 ( 247marketnews.com )- Clearmind Medicine Inc. (NASDAQ: CMND ) filed a patent application with United States Patent and Trademark Office for the use of 3-methylmethcathinone to prevent and/or treat eating disorders either alone...

CMND - Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders

Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated hea...
CMND - Clearmind Medicine CEO Issues Letter to Shareholders

Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under...

CMND - Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression

Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...

CMND - EURN, STI and PUK among pre-market losers

2024-03-20 08:11:18 ET More on pre-market losers & stocks. Prudential: Consider Both Upcoming Results And 2024 Risk Factors Euronav NV: Not Backing Down On The Decarbonization Agenda Euronav NV 2023 Q4 - Results - Earnings Call Presentation Solidion Techn...
Previous 10 Next 10